HerStack · Cluster: Skin · Last reviewed: 28 April 2026

Skin through the oestrogen decline

What perimenopause does to collagen, elasticity, and skin texture — what topical actives address, and where a supplement realistically helps. Sunscreen first, then the formulation question.

By: The HerStack editors · Reading time: ~ 14 min · Words: 2,200 · Citations: 14 sources · Published by: Suggestic Inc, herstack.co.uk

What changes for collagen and elasticity

Read this as the skin side of the same arc the rest of the site reads. Oestrogen withdrawal through the menopausal transition correlates with measurable reductions in skin collagen content and dermal thickness; the Maltese cohort series isolated this carefully across two decades of work. [1] [2]

Three threads of the literature are mature enough to write about with confidence for a woman in this window: the oestrogen-and-collagen mechanism the Calleja-Agius and Brincat reviews map; the GB-authorised claim for vitamin C contribution to normal collagen formation for the normal function of skin, and the biotin and zinc claims that travel with it; and the randomised collagen-peptide trial base, summarised in the de Miranda 2021 meta-analysis of 19 RCTs. [4] [10] [11]

What the research examines

Two ingredient categories on this page carry direct GB-authorised health claims for skin: vitamin C (normal collagen formation for the normal function of skin) and a set of B-vitamins and minerals via the “maintenance of normal skin” wording — biotin, niacin, riboflavin, vitamin A, zinc, iodine, with copper carrying the pigmentation-specific claim. [12]

Research findings

  1. Skin collagen content tracks oestrogen decline through the menopausal transition.

    The Calleja-Agius and Brincat reviews of the Maltese cohort series describe a strong correlation between skin collagen content, dermal thickness and oestrogen status, with a measurable reduction in extensibility-and-elasticity ratios after the final menstrual period. The clinical translation: a substantial share of what reads as age-related change in the skin through this window is mediated by oestrogen withdrawal rather than chronological time alone.

    Source: Best Pract Res Clin Obstet Gynaecol · 2013 · Calleja-Agius et al. · Narrative review of cohort and intervention data

  2. Vitamin C contributes to normal collagen formation for the normal function of skin.

    The GB-authorised wording is direct, and the mechanism is well-described — ascorbate is a cofactor for prolyl and lysyl hydroxylase, the enzymes that stabilise the collagen triple helix. The Pullar 2017 Nutrients review summarises the in-vivo and in-vitro evidence base behind that authorised wording, including the case for adequate dietary intake before the topical question is even raised.

    Source: GB NHC register · Nutrients 2017 · Pullar et al. · Review of mechanism and intake data

  3. Oral collagen peptide trials report changes in skin hydration, elasticity and dermal density at 8–12 weeks.

    The de Miranda 2021 systematic review and meta-analysis pooled 19 randomised controlled trials (n = 1,125, 95% women aged 20–70) of hydrolysed collagen at 2.5–10 g/day for 8–24 weeks, and reported pooled effects on cutometer-measured elasticity and corneometer-measured hydration versus placebo. Trial-level signals run alongside formulation differences (peptide molecular weight, dose, accompanying micronutrients) that the body of the literature has not yet resolved.

    Source: Int J Dermatol · 2021 · de Miranda et al. · Meta-analysis: 19 RCTs, n = 1,125

  4. Daily broad-spectrum sunscreen use over 4.5 years reduced measured photoageing by 24% versus discretionary use in a community RCT.

    The Hughes 2013 Nambour trial randomised 903 Australian adults under 55 to daily broad-spectrum sunscreen plus β-carotene or placebo, against a discretionary-use control. The daily sunscreen arm showed no detectable increase in skin microtopographic ageing markers over the trial period; the discretionary-use group did. β-carotene supplementation showed no overall effect on skin ageing endpoints. The trial sits as the strongest single piece of randomised evidence on a sun-protection intervention.

    Source: Ann Intern Med · 2013 · Hughes et al. · Community RCT, n = 903, 4.5-year follow-up

Evidence at a glance

InterventionForm examinedEvidence baseUK authorised wording
Sunscreen (topical) [11] · Hughes 2013Daily broad-spectrum, SPF 15+Community RCT, n=903, 4.5-year follow-upTopical product — outside the supplement claim framework.
Vitamin C (oral) [04][12] · GB NHC + Pullar 2017Ester-C, ascorbateMechanism + cohort + intake researchContributes to normal collagen formation for the normal function of skin.
Biotin, zinc, niacin, riboflavin (oral) [12] · GB NHCMultiple formsAuthorised-claim mechanismBiotin / zinc / niacin / riboflavin contribute to the maintenance of normal skin.
Oral collagen peptides [05]–[10]Hydrolysed collagen, 2.5–10 g/dayMeta-analysis: 19 RCTs, n=1,125No UK authorised health claim — research-context only.

Reader questions

Is this an oral-versus-topical question, or does the answer involve both?
Both, with a clear hierarchy. The randomised evidence on photoageing endpoints sits with topical interventions — sunscreen first, then prescription-strength topical retinoids — and a supplement does not substitute for either. The trial work on oral collagen peptides describes changes on cutometer and corneometer at 8–12 weeks; that is a different category of outcome to the four-and-a-half-year photoageing endpoints in the Hughes 2013 sunscreen trial. The reading order on this page reflects that. Topicals and sun protection are the foundational interventions for women in this window. Oral nutrients sit underneath them — vitamin C, biotin and the other authorised-claim minerals contribute to normal skin function and to normal collagen formation; oral collagen peptides are described against trial endpoints rather than benefit claims.
Do oral collagen capsules actually do anything?
The honest reading of the trial literature: the randomised trials report effects on instrument-measured endpoints — cutometer elasticity, corneometer hydration, ultrasound dermal density — at 8–12 weeks of supplementation at doses of 2.5–10 g/day. The de Miranda 2021 meta-analysis pooled 19 such trials and found a directionally consistent signal across studies. The honest caveats: most trials are sponsor-linked, the placebo arms vary, and the endpoints sit at the surrogate end of the evidence ladder. Oral collagen peptides do not carry a GB-authorised health claim for skin, so we describe the trial work rather than make benefit statements.
If I had to pick one intervention, what does the research say to start with?
Daily broad-spectrum sunscreen, on photoageing-endpoint grounds. The Hughes 2013 randomised trial is the cleanest piece of evidence on the page — daily use over 4.5 years showed a 24% relative reduction in measured photoageing versus discretionary use. No oral supplement on this page carries randomised evidence at that endpoint or that duration. Sunscreen is the foundational intervention; supplements layer onto it, not over it.
Skin, nails and hair products are everywhere — does the biotin actually do anything?
Biotin carries a GB-authorised claim for the maintenance of normal skin and the maintenance of normal hair, and a separate authorised claim for normal psychological function. The condition for using the claim is source-of-biotin intake, which the Solgar UK supplements on this page clear comfortably. Where the literature is thinner is the case for biotin supplementation in women whose dietary intake is already adequate — frank biotin deficiency is uncommon, and the visible-change studies in unselected populations are mixed. The authorised wording does the heavy lifting; the everyday-claim wording does not.
Why Solgar specifically? Are you the Solgar site?
We are not. HerStack is published by Suggestic, a digital nutrition company. We picked Solgar UK as the reference brand for three reasons set out in our formulation criteria: bioavailable forms across most of the range, transparent dosing on the labels, and third-party testing on the supplements we recommend. Where Solgar’s formulation does not meet our criteria, we say so on the page and link to alternatives.
How often is this article updated?
We review each cluster page against new evidence quarterly, and update the page header date when we make a substantive change. The recommendation rationale below carries its own last-reviewed date so you can see when the formulation reasoning was last checked.

Recommendations: three reference picks with formulation reasoning

Each entry carries the form chosen, the rationale, the authorised claim text, and the Amazon.co.uk link. Sunscreen and topical retinoids sit upstream of every recommendation here. Affiliate disclosure: HerStack is a participant in the Amazon EU Associates Programme.

  1. Solgar Collagen Hyaluronic Acid Complex Tablets - Pack of 30

    Form: Collagen peptides + hyaluronic acid · Speciality formulation

    Rationale: The flagship card on this page, recommended on formulation grounds rather than benefit grounds. The product combines hydrolysed collagen peptides with hyaluronic acid; neither ingredient carries a GB-authorised health claim for skin, so we describe the trial literature on each (Proksch 2014, Asserin 2015, Bolke 2019, Kim 2018, de Miranda 2021 meta-analysis) and decline to make benefit statements. We card the SKU here because it is the closest Solgar UK formulation to the trial protocols, and because pairing it with the vitamin C card below puts an authorised-claim ingredient alongside the research-context ingredient.

    Authorised claim: Research-context only. No UK authorised health claim applies to oral collagen peptides or oral hyaluronic acid for skin.

    Price: £46.73 · Tag: Speciality pick

    Link: https://www.amazon.co.uk/dp/B000Z94Z3Y?tag=herstack-21

  2. Solgar Ester-C Plus 1000 mg Vitamin C Tablets

    Form: Vitamin C · Ester-C, 1000 mg

    Rationale: Vitamin C carries the GB-authorised claim for contribution to normal collagen formation for the normal function of skin, alongside contribution to the reduction of tiredness and fatigue and to normal function of the immune system. Ester-C is a non-acidic calcium-ascorbate complex used by Solgar across the line; the 1000 mg tablet clears the source-of-vitamin-C threshold by a wide margin. Pair with the collagen peptide SKU above as the authorised-claim half of the recommendation.

    Authorised claim: Vitamin C contributes to normal collagen formation for the normal function of skin and contributes to normal function of the immune system.

    Price: £17.00 · Tag: Reference pick

    Link: https://www.amazon.co.uk/dp/B014EQZ7LW?tag=herstack-21

  3. Solgar Skin, Nails and Hair Tablets

    Form: Biotin + zinc + vitamin C combination · Speciality formulation

    Rationale: A combination tablet with biotin, zinc, vitamin C and MSM as the principal constituents. Authorised claims attach to individual nutrients in the formulation: biotin contributes to the maintenance of normal skin and normal hair; zinc contributes to the maintenance of normal skin, hair and nails; vitamin C contributes to normal collagen formation for the normal function of skin. Carded as the foundation tier under the dietary pattern itself, for readers who want one tablet covering the authorised-claim spine for skin maintenance.

    Authorised claim: Biotin contributes to the maintenance of normal skin. Zinc contributes to the maintenance of normal skin. Vitamin C contributes to normal collagen formation for the normal function of skin. (Authorised claims apply to individual nutrients in the formulation; check the current Solgar UK label for exact dosing per nutrient.)

    Price: £18.39 · Tag: Foundation tier

    Link: https://www.amazon.co.uk/dp/B000GJN8KY?tag=herstack-21

What to look for in a brand: three criteria

  1. Authorised-claim wording on the label. Vitamin C, biotin, zinc, niacin, riboflavin, vitamin A, iodine and copper all carry GB-authorised claims for skin function or maintenance. Brands that quote the authorised wording (“contributes to normal collagen formation for the normal function of skin”) are operating inside the regulatory framework; brands that lean on freer benefit language — beyond what the GB register authorises for the ingredient — are operating outside it.
  2. Collagen peptide formulation transparency. Trial-derived effects sit at peptide molecular weights in the 1–5 kDa range and at doses of 2.5–10 g/day. Brands that disclose the molecular-weight range and the daily dose are the ones whose product maps cleanly to the trial protocols. Generic “collagen 500 mg” without molecular-weight disclosure is asking the consumer to trust an unstated specification.
  3. Sun protection sits above the supplement question. The randomised photoageing-prevention evidence is topical. A brand that frames an oral supplement as a substitute for daily sunscreen is misreading the evidence ladder. The honest editorial framing is sunscreen first, then the formulation question.

Citations

  1. Calleja-Agius J, Brincat M, Borg M. Skin connective tissue and ageing.Best Practice & Research Clinical Obstetrics & Gynaecology, 2013;27(5):727-740. PMID 23850161
  2. Calleja-Agius J, Brincat M. The effect of menopause on the skin and other connective tissues. Gynecological Endocrinology, 2012;28(4):273-277. PMID 21970508
  3. Borg M, Brincat S, Camilleri G, Schembri-Wismayer P, Brincat M, Calleja-Agius J. The role of cytokines in skin aging. Climacteric, 2013;16(5):514-521. PMID 23659624
  4. Pullar JM, Carr AC, Vissers MCM. The roles of vitamin C in skin health. Nutrients, 2017;9(8):866. PMID 28805671
  5. Proksch E, Segger D, Degwert J, Schunck M, Zague V, Oesser S. Oral supplementation of specific collagen peptides has beneficial effects on human skin physiology: a double-blind, placebo-controlled study. Skin Pharmacology and Physiology, 2014;27(1):47-55. PMID 23949208
  6. Asserin J, Lati E, Shioya T, Prawitt J. The effect of oral collagen peptide supplementation on skin moisture and the dermal collagen network: evidence from an ex vivo model and randomized, placebo-controlled clinical trials. Journal of Cosmetic Dermatology, 2015;14(4):291-301. PMID 26362110
  7. Kim DU, Chung HC, Choi J, Sakai Y, Lee BY. Oral intake of low-molecular-weight collagen peptide improves hydration, elasticity, and wrinkling in human skin: a randomized, double-blind, placebo-controlled study. Nutrients, 2018;10(7):826. PMID 29949889
  8. Bolke L, Schlippe G, Gerß J, Voss W. A collagen supplement improves skin hydration, elasticity, roughness, and density: results of a randomized, placebo-controlled, blind study. Nutrients, 2019;11(10):2494. PMID 31627309
  9. Choi FD, Sung CT, Juhasz ML, Mesinkovska NA. Oral collagen supplementation: a systematic review of dermatological applications. Journal of Drugs in Dermatology, 2019;18(1):9-16. (Systematic review of 11 RCTs, n=805.) PMID 30681787
  10. de Miranda RB, Weimer P, Rossi RC. Effects of hydrolyzed collagen supplementation on skin aging: a systematic review and meta-analysis. International Journal of Dermatology, 2021;60(12):1449-1461. (Meta-analysis: 19 RCTs, n=1,125; 95% women.) PMID 33742704
  11. Hughes MCB, Williams GM, Baker P, Green AC. Sunscreen and prevention of skin aging: a randomized trial. Annals of Internal Medicine, 2013;158(11):781-790. (Nambour community RCT, n=903, 4.5-year follow-up.) PMID 23732711
  12. GB Nutrition & Health Claims register / Commission Regulation (EU) No 432/2012 (retained). Authorised wording for vitamins and minerals — vitamin C (contribution to normal collagen formation for the normal function of skin), biotin (maintenance of normal skin), niacin, riboflavin, vitamin A, zinc and iodine (normal/maintenance of normal skin), copper (normal skin pigmentation). gov.uk/health-claims
  13. NIH Office of Dietary Supplements. Vitamin C — Health Professional Fact Sheet. ods.od.nih.gov/VitaminC
  14. NIH Office of Dietary Supplements. Biotin — Health Professional Fact Sheet. ods.od.nih.gov/Biotin